{"transactions":[{"id":3555121,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":158340,"kind":"person","name":"Slager David Mark","position":1,"cik":"0001477733","reported_name":"Slager David Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-16T21:01:47.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":4.13,"exercise_date":"2019-04-15","expiration_date":"2029-04-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-19-006513","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390019006513/ownership.xml","form_type":"4"}},{"id":4176522,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":158340,"kind":"person","name":"Slager David Mark","position":1,"cik":"0001477733","reported_name":"Slager David Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2017-11-01T20:39:41.000Z","date":"2017-10-31","kind":"exercise","acquired":false,"shares":16892,"price":1.1796,"value":19925.8032,"ownership":{"direct":false,"nature":"By Regals Fund LP"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The number of shares underlying such warrant and the applicable exercise price reflect a one-for-twelve reverse stock split effected by the issuer on January 22, 2013."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares and warrants were purchased as \"units\" at a price per unit of $4.44 in connection with the Issuer's 2012 private placement.  The consideration was allocated to the shares and warrants based on relative fair value. The value allocated to the warrants was estimated by using the Black Scholes option-pricing model."}],"balance_after":0,"derivative":{"exercise_price":3.7656,"exercise_date":"2012-11-05","expiration_date":"2017-11-05","underlying":"Common Stock","underlying_shares":16892},"source":{"system":"sec-edgar","filing":"0001213900-17-011195","document":"f4103117slager_oramedpharm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017011195/f4103117slager_oramedpharm.xml","form_type":"4"}},{"id":4176521,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":158340,"kind":"person","name":"Slager David Mark","position":1,"cik":"0001477733","reported_name":"Slager David Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-01T20:39:41.000Z","date":"2017-10-31","kind":"exercise","acquired":true,"shares":16892,"price":3.7656,"value":63608.5152,"ownership":{"direct":false,"nature":"By Regals Fund LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Mr. Slager is Managing Member of the general partner of Regals Capital Management LP (\"Regals Management\").  Regals Management is the investment manager of Regals Fund LP (the \"Fund\"). The securities reported herein are held for the account of the Fund. Pursuant to Rule 16a-1(a)(4) under the Act, Mr. Slager disclaims beneficial ownership in the securities owned by the Fund except to the extent, if any, of his pecuniary interest therein."}],"balance_after":1316328,"source":{"system":"sec-edgar","filing":"0001213900-17-011195","document":"f4103117slager_oramedpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017011195/f4103117slager_oramedpharm.xml","form_type":"4"}},{"id":4228677,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":158340,"kind":"person","name":"Slager David Mark","position":1,"cik":"0001477733","reported_name":"Slager David Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2017-08-21T17:56:18.000Z","date":"2017-08-17","kind":"exercise","acquired":false,"shares":112613,"price":1.1796,"value":132838.2948,"ownership":{"direct":false,"nature":"By Regals Fund LP"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The number of shares underlying such warrant and the applicable exercise price reflect a one-for-twelve reverse stock split effected by the issuer on January 22, 2013."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares and warrants were purchased as \"units\" at a price per unit of $4.44 in connection with the Issuer's 2012 private placement. The consideration was allocated to the shares and warrants based on relative fair value. The value allocated to the warrants was estimated by using the Black Scholes option-pricing model."}],"balance_after":0,"derivative":{"exercise_price":3.7656,"exercise_date":"2012-08-28","expiration_date":"2017-08-28","underlying":"Common Stock","underlying_shares":112613},"source":{"system":"sec-edgar","filing":"0001213900-17-008982","document":"f4081717slager_oramendpharm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017008982/f4081717slager_oramendpharm.xml","form_type":"4"}},{"id":4228676,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":158340,"kind":"person","name":"Slager David Mark","position":1,"cik":"0001477733","reported_name":"Slager David Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-21T17:56:18.000Z","date":"2017-08-17","kind":"exercise","acquired":true,"shares":112613,"price":3.7656,"value":424055.5128,"ownership":{"direct":false,"nature":"By Regals Fund LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Mr. Slager is Managing Member of the general partner of Regals Capital Management LP (\"Regals Management\"). Regals Management is the investment manager of Regals Fund LP (the \"Fund\"). The securities reported herein are held for the account of the Fund. Pursuant to Rule 16a-1(a)(4) under the Act, Mr. Slager disclaims beneficial ownership in the securities owned by the Fund except to the extent, if any, of his pecuniary interest therein."}],"balance_after":1299436,"source":{"system":"sec-edgar","filing":"0001213900-17-008982","document":"f4081717slager_oramendpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017008982/f4081717slager_oramendpharm.xml","form_type":"4"}},{"id":4264863,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":158340,"kind":"person","name":"Slager David Mark","position":1,"cik":"0001477733","reported_name":"Slager David Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-05T19:48:03.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":16773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 3 equal installments of 5,591 on each of December 31, 2017, December 31, 2018 and December 31, 2019."}],"balance_after":16773,"derivative":{"exercise_price":7.77,"expiration_date":"2027-06-30","underlying":"Common Stock","underlying_shares":16773},"source":{"system":"sec-edgar","filing":"0001213900-17-007166","document":"f4063017slager_oramed.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017007166/f4063017slager_oramed.xml","form_type":"4"}},{"id":4442807,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":158340,"kind":"person","name":"Slager David Mark","position":1,"cik":"0001477733","reported_name":"Slager David Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-16T20:47:07.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":5697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest immediately."}],"balance_after":5697,"derivative":{"exercise_price":6.23,"expiration_date":"2027-02-09","underlying":"Common Stock","underlying_shares":5697},"source":{"system":"sec-edgar","filing":"0001213900-17-001492","document":"f4020917slager_oramed.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017001492/f4020917slager_oramed.xml","form_type":"4"}}]}